HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
801	23139 Kayed R, Jackson GR Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders CURRENT OPINION IN IMMUNOLOGY. 2009 JUN; 21 (3): 359-363	8	10	46	76
802	23713 Meng XY, Munishkina LA, Fink AL, Uversky VN Molecular Mechanisms Underlying the Flavonoid-Induced Inhibition of alpha-Synuclein Fibrillation BIOCHEMISTRY. 2009 SEP 1; 48 (34): 8206-8224	4	9	46	77
803	24467 Sulzer D Clues to How Alpha-Synuclein Damages Neurons in Parkinson's Disease MOVEMENT DISORDERS. 2010; 25 (3): S27-S31	3	4	46	65
804	24713 Querfurth HW, LaFerla FM MECHANISMS OF DISEASE Alzheimer's Disease NEW ENGLAND JOURNAL OF MEDICINE. 2010 JAN 28; 362 (4): 329-344	18	92	46	193
805	24845 Westerlund M, Hoffer B, Olson L Parkinson's disease: Exit toxins, enter genetics PROGRESS IN NEUROBIOLOGY. 2010 FEB 9; 90 (2): 146-156	1	3	46	143
806	25120 Hoffner G, Andre W, Vanhoutteghem A, Soues S, Djian P Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 APR; 9 (2): 217-231	0	0	46	209
807	25121 Borroni B, Alberici A, Archetti S, Magnani E, Di Luca M, et al. New Insights into Biological Markers of Frontotemporal Lobar Degeneration Spectrum CURRENT MEDICINAL CHEMISTRY. 2010 APR; 17 (10): 1002-1009	1	1	46	64
808	26225 Wentzell J, Kretzschmar D Alzheimer's Disease and tauopathy studies in flies and worms NEUROBIOLOGY OF DISEASE. 2010 OCT; 40 (1): 21-28	0	1	46	94
809	26546 Whittington RA, Papon MA, Chouinard-Decorte F, Planel E Hypothermia and Alzheimer's Disease Neuropathogenic Pathways CURRENT ALZHEIMER RESEARCH. 2010 DEC; 7 (8): 717-725	1	1	46	149
810	6012 Brion JP The role of neurofibrillary tangles in Alzheimer disease ACTA NEUROLOGICA BELGICA. 1998 JUN; 98 (2): 165-174	1	2	45	96
#	Date / Author / Journal	LCS	GCS	LCR	CR
811	6737 Goedert M, Hasegawa M The tauopathies - Toward an experimental animal model AMERICAN JOURNAL OF PATHOLOGY. 1999 JAN; 154 (1): 1-6	20	23	45	63
812	6738 Brion JP, Tremp G, Octave JN Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease AMERICAN JOURNAL OF PATHOLOGY. 1999 JAN; 154 (1): 255-270	112	117	45	76
813	10326 Terwel D, Dewachter I, Van Leuven F Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease NEUROMOLECULAR MEDICINE. 2002; 2 (2): 151-165	23	38	45	85
814	10431 Lee HJ, Choi C, Lee SJ Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 JAN 4; 277 (1): 671-678	94	133	45	66
815	10508 Torreilles F, Touchon J Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer's disease PROGRESS IN NEUROBIOLOGY. 2002 FEB; 66 (3): 191-203	4	15	45	154
816	11117 Martin-Aparicio E, Lucas JJ Molecular basis of Huntington's disease and possible pathogenic mechanisms REVISTA DE NEUROLOGIA. 2002 AUG 1; 35 (3): 212-220	1	2	45	157
817	11289 Moosmann B, Behl C Antioxidants as treatment for neurodegenerative disorders EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2002 OCT; 11 (10): 1407-1435	13	66	45	373
818	11615 Tomasiewicz HG, Flaherty DB, Soria JP, Wood JG Transgenic zebrafish model of neurodegeneration JOURNAL OF NEUROSCIENCE RESEARCH. 2002 DEC 15; 70 (6): 734-745	14	28	45	68
819	11750 Jellinger KA Neuropathological spectrum of synucleinopathies MOVEMENT DISORDERS. 2003; 18: S2-S12	45	64	45	75
820	11855 Dawson TM, Dawson VL Rare genetic mutations shed light on the pathogenesis of Parkinson disease JOURNAL OF CLINICAL INVESTIGATION. 2003 JAN; 111 (2): 145-151	51	103	45	67
#	Date / Author / Journal	LCS	GCS	LCR	CR
821	12125 Lang-Rollin I, Rideout H, Stefanis L Ubiquitinated inclusions and neuronal cell death HISTOLOGY AND HISTOPATHOLOGY. 2003 APR; 18 (2): 509-517	11	23	45	96
822	12409 Sampathu DM, Giasson BI, Pawlyk AC, Trojanowski JQ, Lee VMY Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies AMERICAN JOURNAL OF PATHOLOGY. 2003 JUL; 163 (1): 91-100	54	54	45	66
823	12801 Blennow K, Hampel H CSF markers for incipient Alzheimer's disease LANCET NEUROLOGY. 2003 OCT; 2 (10): 605-613	149	321	45	88
824	12887 van Herpen E, Rosso SM, Serverijnen LA, Yoshida H, Breedveld G, et al. Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R ANNALS OF NEUROLOGY. 2003 NOV; 54 (5): 573-581	28	28	45	49
825	13178 Rochet JC, Outeiro TF, Conway KA, Ding TT, Volles MJ, et al. Interactions among alpha-synuclein, dopamine, and biomembranes - Some clues for understanding neurodegeneration in Parkinson's disease JOURNAL OF MOLECULAR NEUROSCIENCE. 2004; 23 (1-2): 23-33	66	98	45	55
826	13472 Tanaka M, Kim YM, Lee G, Junn E, Iwatsubo T, et al. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 FEB 6; 279 (6): 4625-4631	81	154	45	63
827	13637 Lin H, Zhai JB, Canete-Soler R, Schlaepfer WW 3 ' untranslated region in a light neurofilament (NF-L) mRNA triggers aggregation of NF-L and mutant superoxide dismutase 1 proteins in neuronal cells JOURNAL OF NEUROSCIENCE. 2004 MAR 17; 24 (11): 2716-2726	8	19	45	86
828	13984 Walsh DM, Selkoe DJ Oligomers in the brain: The emerging role of soluble protein aggregates in neurodegeneration PROTEIN AND PEPTIDE LETTERS. 2004 JUN; 11 (3): 213-228	51	169	45	139
829	14069 Ross CA, Poirier MA Protein aggregation and neurodegenerative disease NATURE MEDICINE. 2004 JUL; 10 (7): S10-S17	151	565	45	125
830	14226 Alonso AD, Mederlyova A, Novak M, Grundke-Iqbal I, Iqbal K Promotion of hyperphosphorylation by frontotemporal dementia tau mutations JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 AUG 13; 279 (33): 34873-34881	66	76	45	62
#	Date / Author / Journal	LCS	GCS	LCR	CR
831	14232 Li WX, Lesuisse C, Xu YQ, Troncoso JC, Price DL, et al. Stabilization of alpha-synuclein protein with aging and familial Parkinson's disease-linked A53T mutation JOURNAL OF NEUROSCIENCE. 2004 AUG 18; 24 (33): 7400-7409	38	48	45	65
832	14468 Choi W, Zibaee S, Jakes R, Serpell LC, Davletov B, et al. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein FEBS LETTERS. 2004 OCT 22; 576 (3): 363-368	65	69	45	59
833	15480 Mishizen-Eberz AJ, Norris EH, Giasson BI, Hodara R, Ischiropoulos H, et al. Cleavage of alpha-synuclein by calpain: Potential role in degradation of fibrillized and nitrated species of alpha-synuclein BIOCHEMISTRY. 2005 MAY 31; 44 (21): 7818-7829	28	30	45	61
834	15746 Wenning GK, Jellinger KA The role of alpha-synuclein and tau in neurodegenerative movement disorders CURRENT OPINION IN NEUROLOGY. 2005 AUG; 18 (4): 357-362	14	19	45	56
835	16787 Lee CH, Kim HJ, Lee JH, Cho HJ, Kim J, et al. Dequalinium-induced protofibril formation of alpha-synuclein JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 FEB 10; 281 (6): 3463-3472	7	11	45	74
836	17049 Tofaris GK, Reitbock PG, Humby T, Lambourne SL, O'Connell M, et al. Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha- synuclein (1-120): Implications for Lewy body disorders JOURNAL OF NEUROSCIENCE. 2006 APR 12; 26 (15): 3942-3950	60	66	45	59
837	17684 Barre P, Eliezer D Folding of the repeat domain of tau upon binding to lipid surfaces JOURNAL OF MOLECULAR BIOLOGY. 2006 SEP 15; 362 (2): 312-326	5	9	45	87
838	17898 Huang HC, Klein PS Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease CURRENT DRUG TARGETS. 2006 NOV; 7 (11): 1389-1397	6	30	45	174
839	18762 Periquet M, Fulga T, Myllykangas L, Schlossmacher MG, Feany MB Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo JOURNAL OF NEUROSCIENCE. 2007 MAR 21; 27 (12): 3338-3346	49	54	45	55
840	18797 Zhu XW, Lee HG, Perry G, Smith MA Alzheimer disease, the two-hit hypothesis: An update BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2007 APR; 1772 (4): 494-502	13	60	45	131
#	Date / Author / Journal	LCS	GCS	LCR	CR
841	19149 Bandyopadhyay B, Li GB, Yin HS, Kuret J Tau aggregation and toxicity in a cell culture model of tauopathy JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 JUN 1; 282 (22): 16454-16464	19	28	45	76
842	19997 Planel E, Tatebayashi Y, Miyasaka T, Liu L, Wang LL, et al. Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms JOURNAL OF NEUROSCIENCE. 2007 DEC 12; 27 (50): 13635-13648	13	41	45	118
843	20157 Khurana V Modeling Tauopathy in the Fruit Fly Drosophila melanogaster JOURNAL OF ALZHEIMERS DISEASE. 2008; 15 (4): 541-553	8	12	45	71
844	20859 Cruts M, Van Broeckhoven C Loss of progranulin function in frontotemporal lobar degeneration TRENDS IN GENETICS. 2008 APR; 24 (4): 186-194	20	26	45	97
845	21045 Congdon EE, Kim S, Bonchak J, Songrug T, Matzavinos A, et al. Nucleation-dependent tau filament formation - The importance of dimerization and an estimation of elementary rate constants JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 MAY 16; 283 (20): 13806-13816	17	20	45	82
846	21230 Waxman EA, Duda JE, Giasson BI Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusions ACTA NEUROPATHOLOGICA. 2008 JUL; 116 (1): 37-46	9	10	45	52
847	21975 Mackenzie IRA, Rademakers R The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia CURRENT OPINION IN NEUROLOGY. 2008 DEC; 21 (6): 693-700	14	15	45	63
848	22084 Leboeuf AC, Levy SF, Gaylord M, Bhattacharya A, Singh AK, et al. FTDP-17 Mutations in Tau Alter the Regulation of Microtubule Dynamics AN "ALTERNATIVE CORE" MODEL FOR NORMAL AND PATHOLOGICAL TAU ACTION JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 DEC 26; 283 (52): 36406-36415	4	6	45	65
849	22209 Lee S, Jung C, Lee G, Hall GF Exonic Point Mutations of Human Tau Enhance its Toxicity and Cause Characteristic Changes in Neuronal Morphology, Tau Distribution and Tau Phosphorylation in the Lamprey Cellular Model of Tauopathy JOURNAL OF ALZHEIMERS DISEASE. 2009; 16 (1): 99-111	1	2	45	55
850	22380 Moussa CEH Parkin Attenuates Wild-Type tau Modification in the Presence of beta- Amyloid and alpha-Synuclein JOURNAL OF MOLECULAR NEUROSCIENCE. 2009 JAN; 37 (1): 25-36	2	3	45	72
#	Date / Author / Journal	LCS	GCS	LCR	CR
851	22527 Jeibmann A, Paulus W Drosophila melanogaster as a Model Organism of Brain Diseases INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 FEB; 10 (2): 407-440	2	5	45	168
852	22615 Lu XH, Fleming SM, Meurers B, Ackerson LC, Mortazavi F, et al. Bacterial Artificial Chromosome Transgenic Mice Expressing a Truncated Mutant Parkin Exhibit Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Degeneration, and Accumulation of Proteinase K- Resistant alpha-Synuclein JOURNAL OF NEUROSCIENCE. 2009 FEB 18; 29 (7): 1962-1976	11	20	45	104
853	23280 Banerjee R, Starkov AA, Beal MF, Thomas B Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 651-663	9	23	45	228
854	23630 Hu WT, Grossman M TDP-43 and frontotemporal dementia CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS. 2009 SEP; 9 (5): 353-358	0	1	45	54
855	23993 Wenning GK, Stefanova N Recent developments in multiple system atrophy JOURNAL OF NEUROLOGY. 2009 NOV; 256 (11): 1791-1808	5	5	45	217
856	24638 Saatman KE, Creed J, Raghupathi R Calpain as a Therapeutic Target in Traumatic Brain Injury NEUROTHERAPEUTICS. 2010 JAN; 7 (1): 31-42	2	4	45	93
857	24841 Bodner CR, Maltsev AS, Dobson CM, Bax A Differential Phospholipid Binding of alpha-Synuclein Variants Implicated in Parkinson's Disease Revealed by Solution NMR Spectroscopy BIOCHEMISTRY. 2010 FEB 9; 49 (5): 862-871	8	10	45	61
858	25031 Barber SC, Shaw PJ Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target FREE RADICAL BIOLOGY AND MEDICINE. 2010 MAR 1; 48 (5): 629-641	6	12	45	248
859	25305 Grill JD, Cummings JL Current therapeutic targets for the treatment of Alzheimer's disease EXPERT REVIEW OF NEUROTHERAPEUTICS. 2010 MAY; 10 (5): 711-728	2	3	45	292
860	25332 Pennington K, Peng JH, Hung CC, Banks RE, Robinson PA Differential Effects of Wild-Type and A53T Mutant Isoform of Alpha- Synuclein on the Mitochondrial Proteome of Differentiated SH-SY5Y Cells JOURNAL OF PROTEOME RESEARCH. 2010 MAY; 9 (5): 2390-2401	1	2	45	72
#	Date / Author / Journal	LCS	GCS	LCR	CR
861	25374 Perez-Sanchez F, Milan M, Buendia P, Cano-Jaimez M, Ambrosio S, et al. PROSURVIVAL EFFECT OF HUMAN WILD-TYPE A-SYNUCLEIN ON MPTP-INDUCED TOXICITY TO CENTRAL BUT NOT PERIPHERAL CATECHOLAMINERGIC NEURONS ISOLATED FROM TRANSGENIC MICE NEUROSCIENCE. 2010 MAY 5; 167 (2): 261-276	2	2	45	72
862	25589 Rosales-Corral S, Reiter RJ, Tan DX, Ortiz GG, Lopez-Armas G Functional Aspects of Redox Control During Neuroinflammation ANTIOXIDANTS & REDOX SIGNALING. 2010 JUL; 13 (2): 193-247	0	3	45	612
863	25788 Ulusoy A, Febbraro F, Jensen PH, Kirik D, Romero-Ramos M Co-expression of C-terminal truncated alpha-synuclein enhances full- length alpha-synuclein-induced pathology EUROPEAN JOURNAL OF NEUROSCIENCE. 2010 AUG; 32 (3): 409-422	2	2	45	54
864	26077 Georgieva ER, Ramlall TF, Borbat PP, Freed JH, Eliezer D The Lipid-binding Domain of Wild Type and Mutant alpha-Synuclein COMPACTNESS AND INTERCONVERSION BETWEEN THE BROKEN AND EXTENDED HELIX FORMS JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 SEP 3; 285 (36): 28261-28274	2	2	45	77
865	26714 Parchi P, Strammiello R, Giese A, Kretzschmar H Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future ACTA NEUROPATHOLOGICA. 2011 JAN; 121 (1): 91-112	0	1	45	137
866	26946 Masters CL, Kril JJ, Halliday GM, Pamphlett R, Collins S, et al. Overview and recent advances in neuropathology. Part 2: Neurodegeneration PATHOLOGY. 2011 FEB; 43 (2): 93-102	0	0	45	86
867	3140 AVILA J, DOMINGUEZ J, DIAZNIDO J REGULATION OF MICROTUBULE DYNAMICS BY MICROTUBULE-ASSOCIATED PROTEIN EXPRESSION AND PHOSPHORYLATION DURING NEURONAL DEVELOPMENT INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY. 1994 MAR; 38 (1): 13-25	31	121	44	207
868	7474 Hashimoto M, Masliah E Alpha-synuclein in Lewy body disease and Alzheimer's disease BRAIN PATHOLOGY. 1999 OCT; 9 (4): 707-720	101	132	44	139
869	7823 Jellinger KA Cell death mechanisms in Parkinson's disease JOURNAL OF NEURAL TRANSMISSION. 2000; 107 (1): 1-29	34	145	44	237
870	10088 Kahle PJ, Neumann M, Ozmen L, Muller V, Odoy S, et al. Selective insolubility of alpha-Synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model AMERICAN JOURNAL OF PATHOLOGY. 2001 DEC; 159 (6): 2215-2225	111	111	44	54
#	Date / Author / Journal	LCS	GCS	LCR	CR
871	11429 Neumann M, Kahle PJ, Giasson BI, Ozmen L, Borroni E, et al. Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies JOURNAL OF CLINICAL INVESTIGATION. 2002 NOV; 110 (10): 1429-1439	104	104	44	52
872	11455 Robinson SR, Bishop GM A beta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease NEUROBIOLOGY OF AGING. 2002 NOV-DEC; 23 (6): 1051-1072	12	60	44	303
873	12640 Higgins GA, Jacobsen H Transgenic mouse models of Alzheimer's disease: phenotype and application BEHAVIOURAL PHARMACOLOGY. 2003 SEP; 14 (5-6): 419-438	23	80	44	182
874	13230 Miller DW, Cookson MR, Dickson DW Glial cell inclusions and the pathogenesis of neurodegenerative diseases NEURON GLIA BIOLOGY. 2004; 1: 13-21	5	11	44	87
875	13535 Scarmeas N, Honig LS Frontotemporal degenerative dementias CLINICAL NEUROSCIENCE RESEARCH. 2004 MAR-APR; 3 (6): 449-460	0	0	44	201
876	14425 Forman MS, Trojanowski JQ, Lee VMY Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs NATURE MEDICINE. 2004 OCT; 10 (10): 1055-1063	206	206	44	104
877	14526 Healy DG, Abou-Sleiman PM, Wood NW PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism LANCET NEUROLOGY. 2004 NOV; 3 (11): 652-662	10	25	44	128
878	14576 Hodara R, Norris EH, Giasson BI, Mishizen-Eberz AJ, Lynch DR, et al. Functional consequences of alpha-synuclein tyrosine nitration - Diminished binding to lipid vesicles and increased fibril formation JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 NOV 12; 279 (46): 47746-47753	54	67	44	55
879	14966 King ME Can tau filaments be both physiologically beneficial and toxic? BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 260-267	6	9	44	70
880	16813 Uryu K, Richter-Landsberg C, Welch W, Sun E, Goldbaum O, et al. Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies AMERICAN JOURNAL OF PATHOLOGY. 2006 MAR; 168 (3): 947-961	30	30	44	70
#	Date / Author / Journal	LCS	GCS	LCR	CR
881	17440 Schindowski K, Bretteville A, Leroy K, Begard S, Brion JP, et al. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits AMERICAN JOURNAL OF PATHOLOGY. 2006 AUG; 169 (2): 599-616	42	53	44	65
882	17448 Surgucheva I, McMahon B, Surguchov A gamma-Synuclein has a dynamic intracellular localization CELL MOTILITY AND THE CYTOSKELETON. 2006 AUG; 63 (8): 447-458	6	6	44	64
883	18777 Terni B, Rey MJ, Boluda S, Torrejon-Escribano B, Sabate MP, et al. Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer's disease ACTA NEUROPATHOLOGICA. 2007 APR; 113 (4): 403-416	6	8	44	65
884	18817 Tsigelny IF, Bar-On P, Sharikov Y, Crews L, Hashimoto M, et al. Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein FEBS JOURNAL. 2007 APR; 274 (7): 1862-1877	31	43	44	74
885	19038 Emadi S, Barkhordarian H, Wang MS, Schulz P, Sierks MR Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein- induced toxicity JOURNAL OF MOLECULAR BIOLOGY. 2007 MAY 11; 368 (4): 1132-1144	23	41	44	66
886	19126 Mazanetz MP, Fischer PM Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases NATURE REVIEWS DRUG DISCOVERY. 2007 JUN; 6 (6): 464-479	46	95	44	164
887	19816 Jiang HB, Wu YC, Nakamura M, Liang YD, Tanaka YJ, et al. Parkinson's disease genetic mutations increase cell susceptibility to stress: Mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death NEUROBIOLOGY OF AGING. 2007 NOV; 28 (11): 1709-1717	7	13	44	89
888	20140 Gotz J, Ittner LM, Fandrich M, Schonrock N Is tau aggregation toxic or protective: A sensible question in the absence of sensitive methods? JOURNAL OF ALZHEIMERS DISEASE. 2008; 14 (4): 423-429	3	6	44	75
889	20344 Eriksen JL, Mackenzie IRA Progranulin: normal function and role in neurodegeneration JOURNAL OF NEUROCHEMISTRY. 2008 JAN; 104 (2): 287-297	15	27	44	93
890	20567 Mihajlovic M, Lazaridis T Membrane-bound structure and energetics of alpha-synuclein PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS. 2008 FEB 15; 70 (3): 761-778	7	14	44	90
#	Date / Author / Journal	LCS	GCS	LCR	CR
891	20975 Yu WH, Matsuoka Y, Sziraki I, Hashim A, LaFrancois J, et al. Increased dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in transgenic mice expressing mutant A53T alpha-synuclein NEUROCHEMICAL RESEARCH. 2008 MAY; 33 (5): 902-911	7	7	44	74
892	21223 Reynolds CH, Garwood CJ, Wray S, Price C, Kellie S, et al. Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase C gamma 1, Grb2, and Src family kinases JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 JUN 27; 283 (26): 18177-18186	15	29	44	84
893	21268 Deshpande A, Win KM, Busciglio J Tau isoform expression and regulation in human cortical neurons FASEB JOURNAL. 2008 JUL; 22 (7): 2357-2367	5	7	44	69
894	21727 Shadrina MI, Slominsky PA Mitochondrial Dysfunction and Oxidative Damage in the Molecular Pathology of Parkinson's Disease MOLECULAR BIOLOGY. 2008 OCT; 42 (5): 720-728	0	0	44	92
895	22111 Haydar SN, Yun HED, Staal RGW, Hirst WD Small-Molecule Protein-Protein Interaction Inhibitors as Therapeutic Agents for Neurodegenerative Diseases: Recent Progress and Future Directions ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 44. 2009; 44: 51-69	1	3	44	84
896	22688 Marongiu R, Spencer B, Crews L, Adame A, Patrick C, et al. Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux JOURNAL OF NEUROCHEMISTRY. 2009 MAR; 108 (6): 1561-1574	6	17	44	92
897	23078 Han D, Qureshi HY, Lu YF, Paudel HK Familial FTDP-17 Missense Mutations Inhibit Microtubule Assembly- promoting Activity of Tau by Increasing Phosphorylation at Ser(202) in Vitro JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 MAY 15; 284 (20): 13422-13433	4	4	44	53
898	23279 Tsang AHK, Chung KKK Oxidative and nitrosative stress in Parkinson's disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 643-650	5	19	44	121
899	23894 Morfini GA, Burns M, Binder LI, Kanaan NM, LaPointe N, et al. Axonal Transport Defects in Neurodegenerative Diseases JOURNAL OF NEUROSCIENCE. 2009 OCT 14; 29 (41): 12776-12786	10	30	44	125
900	23940 Gitcho MA, Bigio EH, Mishra M, Johnson N, Weintraub S, et al. TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy ACTA NEUROPATHOLOGICA. 2009 NOV; 118 (5): 633-645	14	14	44	63

Date / Author / Journal

LCS

GCS

LCR

801

23139 Kayed R, Jackson GR

Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders

CURRENT OPINION IN IMMUNOLOGY. 2009 JUN; 21 (3): 359-363

802

23713 Meng XY, Munishkina LA, Fink AL, Uversky VN

Molecular Mechanisms Underlying the Flavonoid-Induced Inhibition of alpha-Synuclein Fibrillation

BIOCHEMISTRY. 2009 SEP 1; 48 (34): 8206-8224

803

24467 Sulzer D

Clues to How Alpha-Synuclein Damages Neurons in Parkinson's Disease

MOVEMENT DISORDERS. 2010; 25 (3): S27-S31

804

24713 Querfurth HW, LaFerla FM

MECHANISMS OF DISEASE Alzheimer's Disease

NEW ENGLAND JOURNAL OF MEDICINE. 2010 JAN 28; 362 (4): 329-344

193

805

24845 Westerlund M, Hoffer B, Olson L

Parkinson's disease: Exit toxins, enter genetics

PROGRESS IN NEUROBIOLOGY. 2010 FEB 9; 90 (2): 146-156

143

806

25120 Hoffner G, Andre W, Vanhoutteghem A, Soues S, Djian P

Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 APR; 9 (2): 217-231

209

807

25121 Borroni B, Alberici A, Archetti S, Magnani E, Di Luca M, et al.

New Insights into Biological Markers of Frontotemporal Lobar Degeneration Spectrum

CURRENT MEDICINAL CHEMISTRY. 2010 APR; 17 (10): 1002-1009

808

26225 Wentzell J, Kretzschmar D

Alzheimer's Disease and tauopathy studies in flies and worms

NEUROBIOLOGY OF DISEASE. 2010 OCT; 40 (1): 21-28

809

26546 Whittington RA, Papon MA, Chouinard-Decorte F, Planel E

Hypothermia and Alzheimer's Disease Neuropathogenic Pathways

CURRENT ALZHEIMER RESEARCH. 2010 DEC; 7 (8): 717-725

149

810

6012 Brion JP

The role of neurofibrillary tangles in Alzheimer disease

ACTA NEUROLOGICA BELGICA. 1998 JUN; 98 (2): 165-174

Date / Author / Journal

LCS

GCS

LCR

811

6737 Goedert M, Hasegawa M

The tauopathies - Toward an experimental animal model

AMERICAN JOURNAL OF PATHOLOGY. 1999 JAN; 154 (1): 1-6

812

6738 Brion JP, Tremp G, Octave JN

Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease

AMERICAN JOURNAL OF PATHOLOGY. 1999 JAN; 154 (1): 255-270

112

117

813

10326 Terwel D, Dewachter I, Van Leuven F

Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease

NEUROMOLECULAR MEDICINE. 2002; 2 (2): 151-165

814

10431 Lee HJ, Choi C, Lee SJ

Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 JAN 4; 277 (1): 671-678

133

815

10508 Torreilles F, Touchon J

Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer's disease

PROGRESS IN NEUROBIOLOGY. 2002 FEB; 66 (3): 191-203

154

816

11117 Martin-Aparicio E, Lucas JJ

Molecular basis of Huntington's disease and possible pathogenic mechanisms

REVISTA DE NEUROLOGIA. 2002 AUG 1; 35 (3): 212-220

157

817

11289 Moosmann B, Behl C

Antioxidants as treatment for neurodegenerative disorders

EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2002 OCT; 11 (10): 1407-1435

373

818

11615 Tomasiewicz HG, Flaherty DB, Soria JP, Wood JG

Transgenic zebrafish model of neurodegeneration

JOURNAL OF NEUROSCIENCE RESEARCH. 2002 DEC 15; 70 (6): 734-745

819

11750 Jellinger KA

Neuropathological spectrum of synucleinopathies

MOVEMENT DISORDERS. 2003; 18: S2-S12

820

11855 Dawson TM, Dawson VL

Rare genetic mutations shed light on the pathogenesis of Parkinson disease

JOURNAL OF CLINICAL INVESTIGATION. 2003 JAN; 111 (2): 145-151

103

Date / Author / Journal

LCS

GCS

LCR

821

12125 Lang-Rollin I, Rideout H, Stefanis L

Ubiquitinated inclusions and neuronal cell death

HISTOLOGY AND HISTOPATHOLOGY. 2003 APR; 18 (2): 509-517

822

12409 Sampathu DM, Giasson BI, Pawlyk AC, Trojanowski JQ, Lee VMY

Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies

AMERICAN JOURNAL OF PATHOLOGY. 2003 JUL; 163 (1): 91-100

823

12801 Blennow K, Hampel H

CSF markers for incipient Alzheimer's disease

LANCET NEUROLOGY. 2003 OCT; 2 (10): 605-613

149

321

824

12887 van Herpen E, Rosso SM, Serverijnen LA, Yoshida H, Breedveld G, et al.

Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R

ANNALS OF NEUROLOGY. 2003 NOV; 54 (5): 573-581

825

13178 Rochet JC, Outeiro TF, Conway KA, Ding TT, Volles MJ, et al.

Interactions among alpha-synuclein, dopamine, and biomembranes - Some clues for understanding neurodegeneration in Parkinson's disease

JOURNAL OF MOLECULAR NEUROSCIENCE. 2004; 23 (1-2): 23-33

826

13472 Tanaka M, Kim YM, Lee G, Junn E, Iwatsubo T, et al.

Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 FEB 6; 279 (6): 4625-4631

154

827

13637 Lin H, Zhai JB, Canete-Soler R, Schlaepfer WW

3 ' untranslated region in a light neurofilament (NF-L) mRNA triggers aggregation of NF-L and mutant superoxide dismutase 1 proteins in neuronal cells

JOURNAL OF NEUROSCIENCE. 2004 MAR 17; 24 (11): 2716-2726

828

13984 Walsh DM, Selkoe DJ

Oligomers in the brain: The emerging role of soluble protein aggregates in neurodegeneration

PROTEIN AND PEPTIDE LETTERS. 2004 JUN; 11 (3): 213-228

169

139

829

14069 Ross CA, Poirier MA

Protein aggregation and neurodegenerative disease

NATURE MEDICINE. 2004 JUL; 10 (7): S10-S17

151

565

125

830

14226 Alonso AD, Mederlyova A, Novak M, Grundke-Iqbal I, Iqbal K

Promotion of hyperphosphorylation by frontotemporal dementia tau mutations

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 AUG 13; 279 (33): 34873-34881

Date / Author / Journal

LCS

GCS

LCR

831

14232 Li WX, Lesuisse C, Xu YQ, Troncoso JC, Price DL, et al.

Stabilization of alpha-synuclein protein with aging and familial Parkinson's disease-linked A53T mutation

JOURNAL OF NEUROSCIENCE. 2004 AUG 18; 24 (33): 7400-7409

832

14468 Choi W, Zibaee S, Jakes R, Serpell LC, Davletov B, et al.

Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein

FEBS LETTERS. 2004 OCT 22; 576 (3): 363-368

833

15480 Mishizen-Eberz AJ, Norris EH, Giasson BI, Hodara R, Ischiropoulos H, et al.

Cleavage of alpha-synuclein by calpain: Potential role in degradation of fibrillized and nitrated species of alpha-synuclein

BIOCHEMISTRY. 2005 MAY 31; 44 (21): 7818-7829

834

15746 Wenning GK, Jellinger KA

The role of alpha-synuclein and tau in neurodegenerative movement disorders

CURRENT OPINION IN NEUROLOGY. 2005 AUG; 18 (4): 357-362

835

16787 Lee CH, Kim HJ, Lee JH, Cho HJ, Kim J, et al.

Dequalinium-induced protofibril formation of alpha-synuclein

JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 FEB 10; 281 (6): 3463-3472

836

17049 Tofaris GK, Reitbock PG, Humby T, Lambourne SL, O'Connell M, et al.

Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha- synuclein (1-120): Implications for Lewy body disorders

JOURNAL OF NEUROSCIENCE. 2006 APR 12; 26 (15): 3942-3950

837

17684 Barre P, Eliezer D

Folding of the repeat domain of tau upon binding to lipid surfaces

JOURNAL OF MOLECULAR BIOLOGY. 2006 SEP 15; 362 (2): 312-326

838

17898 Huang HC, Klein PS

Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease

CURRENT DRUG TARGETS. 2006 NOV; 7 (11): 1389-1397

174

839

18762 Periquet M, Fulga T, Myllykangas L, Schlossmacher MG, Feany MB

Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo

JOURNAL OF NEUROSCIENCE. 2007 MAR 21; 27 (12): 3338-3346

840

18797 Zhu XW, Lee HG, Perry G, Smith MA

Alzheimer disease, the two-hit hypothesis: An update

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2007 APR; 1772 (4): 494-502

131

Date / Author / Journal

LCS

GCS

LCR

841

19149 Bandyopadhyay B, Li GB, Yin HS, Kuret J

Tau aggregation and toxicity in a cell culture model of tauopathy

JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 JUN 1; 282 (22): 16454-16464

842

19997 Planel E, Tatebayashi Y, Miyasaka T, Liu L, Wang LL, et al.

Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms

JOURNAL OF NEUROSCIENCE. 2007 DEC 12; 27 (50): 13635-13648

118

843

20157 Khurana V

Modeling Tauopathy in the Fruit Fly Drosophila melanogaster

JOURNAL OF ALZHEIMERS DISEASE. 2008; 15 (4): 541-553

844

20859 Cruts M, Van Broeckhoven C

Loss of progranulin function in frontotemporal lobar degeneration

TRENDS IN GENETICS. 2008 APR; 24 (4): 186-194

845

21045 Congdon EE, Kim S, Bonchak J, Songrug T, Matzavinos A, et al.

Nucleation-dependent tau filament formation - The importance of dimerization and an estimation of elementary rate constants

JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 MAY 16; 283 (20): 13806-13816

846

21230 Waxman EA, Duda JE, Giasson BI

Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusions

ACTA NEUROPATHOLOGICA. 2008 JUL; 116 (1): 37-46

847

21975 Mackenzie IRA, Rademakers R

The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia

CURRENT OPINION IN NEUROLOGY. 2008 DEC; 21 (6): 693-700

848

22084 Leboeuf AC, Levy SF, Gaylord M, Bhattacharya A, Singh AK, et al.

FTDP-17 Mutations in Tau Alter the Regulation of Microtubule Dynamics AN "ALTERNATIVE CORE" MODEL FOR NORMAL AND PATHOLOGICAL TAU ACTION

JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 DEC 26; 283 (52): 36406-36415

849

22209 Lee S, Jung C, Lee G, Hall GF

Exonic Point Mutations of Human Tau Enhance its Toxicity and Cause Characteristic Changes in Neuronal Morphology, Tau Distribution and Tau Phosphorylation in the Lamprey Cellular Model of Tauopathy

JOURNAL OF ALZHEIMERS DISEASE. 2009; 16 (1): 99-111

850

22380 Moussa CEH

Parkin Attenuates Wild-Type tau Modification in the Presence of beta- Amyloid and alpha-Synuclein

JOURNAL OF MOLECULAR NEUROSCIENCE. 2009 JAN; 37 (1): 25-36

Date / Author / Journal

LCS

GCS

LCR

851

22527 Jeibmann A, Paulus W

Drosophila melanogaster as a Model Organism of Brain Diseases

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 FEB; 10 (2): 407-440

168

852

22615 Lu XH, Fleming SM, Meurers B, Ackerson LC, Mortazavi F, et al.JOURNAL OF NEUROSCIENCE. 2009 FEB 18; 29 (7): 1962-1976

104

853

23280 Banerjee R, Starkov AA, Beal MF, Thomas B

Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 651-663

228

854

23630 Hu WT, Grossman M

TDP-43 and frontotemporal dementia

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS. 2009 SEP; 9 (5): 353-358

855

23993 Wenning GK, Stefanova N

Recent developments in multiple system atrophy

JOURNAL OF NEUROLOGY. 2009 NOV; 256 (11): 1791-1808

217

856

24638 Saatman KE, Creed J, Raghupathi R

Calpain as a Therapeutic Target in Traumatic Brain Injury

NEUROTHERAPEUTICS. 2010 JAN; 7 (1): 31-42

857

24841 Bodner CR, Maltsev AS, Dobson CM, Bax A

Differential Phospholipid Binding of alpha-Synuclein Variants Implicated in Parkinson's Disease Revealed by Solution NMR Spectroscopy

BIOCHEMISTRY. 2010 FEB 9; 49 (5): 862-871

858

25031 Barber SC, Shaw PJ

Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target

FREE RADICAL BIOLOGY AND MEDICINE. 2010 MAR 1; 48 (5): 629-641

248

859

25305 Grill JD, Cummings JL

Current therapeutic targets for the treatment of Alzheimer's disease

EXPERT REVIEW OF NEUROTHERAPEUTICS. 2010 MAY; 10 (5): 711-728

292

860

25332 Pennington K, Peng JH, Hung CC, Banks RE, Robinson PA

Differential Effects of Wild-Type and A53T Mutant Isoform of Alpha- Synuclein on the Mitochondrial Proteome of Differentiated SH-SY5Y Cells

JOURNAL OF PROTEOME RESEARCH. 2010 MAY; 9 (5): 2390-2401

Date / Author / Journal

LCS

GCS

LCR

861

25374 Perez-Sanchez F, Milan M, Buendia P, Cano-Jaimez M, Ambrosio S, et al.

PROSURVIVAL EFFECT OF HUMAN WILD-TYPE A-SYNUCLEIN ON MPTP-INDUCED TOXICITY TO CENTRAL BUT NOT PERIPHERAL CATECHOLAMINERGIC NEURONS ISOLATED FROM TRANSGENIC MICE

NEUROSCIENCE. 2010 MAY 5; 167 (2): 261-276

862

25589 Rosales-Corral S, Reiter RJ, Tan DX, Ortiz GG, Lopez-Armas G

Functional Aspects of Redox Control During Neuroinflammation

ANTIOXIDANTS & REDOX SIGNALING. 2010 JUL; 13 (2): 193-247

612

863

25788 Ulusoy A, Febbraro F, Jensen PH, Kirik D, Romero-Ramos M

Co-expression of C-terminal truncated alpha-synuclein enhances full- length alpha-synuclein-induced pathology

EUROPEAN JOURNAL OF NEUROSCIENCE. 2010 AUG; 32 (3): 409-422

864

26077 Georgieva ER, Ramlall TF, Borbat PP, Freed JH, Eliezer D

The Lipid-binding Domain of Wild Type and Mutant alpha-Synuclein COMPACTNESS AND INTERCONVERSION BETWEEN THE BROKEN AND EXTENDED HELIX FORMS

JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 SEP 3; 285 (36): 28261-28274

865

26714 Parchi P, Strammiello R, Giese A, Kretzschmar H

Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future

ACTA NEUROPATHOLOGICA. 2011 JAN; 121 (1): 91-112

137

866

26946 Masters CL, Kril JJ, Halliday GM, Pamphlett R, Collins S, et al.

Overview and recent advances in neuropathology. Part 2: Neurodegeneration

PATHOLOGY. 2011 FEB; 43 (2): 93-102

867

3140 AVILA J, DOMINGUEZ J, DIAZNIDO J

REGULATION OF MICROTUBULE DYNAMICS BY MICROTUBULE-ASSOCIATED PROTEIN EXPRESSION AND PHOSPHORYLATION DURING NEURONAL DEVELOPMENT

INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY. 1994 MAR; 38 (1): 13-25

121

207

868

7474 Hashimoto M, Masliah E

Alpha-synuclein in Lewy body disease and Alzheimer's disease

BRAIN PATHOLOGY. 1999 OCT; 9 (4): 707-720

101

132

139

869

7823 Jellinger KA

Cell death mechanisms in Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION. 2000; 107 (1): 1-29

145

237

870

10088 Kahle PJ, Neumann M, Ozmen L, Muller V, Odoy S, et al.

Selective insolubility of alpha-Synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model

AMERICAN JOURNAL OF PATHOLOGY. 2001 DEC; 159 (6): 2215-2225

111

Date / Author / Journal

LCS

GCS

LCR

871

11429 Neumann M, Kahle PJ, Giasson BI, Ozmen L, Borroni E, et al.

Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies

JOURNAL OF CLINICAL INVESTIGATION. 2002 NOV; 110 (10): 1429-1439

104

872

11455 Robinson SR, Bishop GM

A beta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease

NEUROBIOLOGY OF AGING. 2002 NOV-DEC; 23 (6): 1051-1072

303

873

12640 Higgins GA, Jacobsen H

Transgenic mouse models of Alzheimer's disease: phenotype and application

BEHAVIOURAL PHARMACOLOGY. 2003 SEP; 14 (5-6): 419-438

182

874

13230 Miller DW, Cookson MR, Dickson DW

Glial cell inclusions and the pathogenesis of neurodegenerative diseases

NEURON GLIA BIOLOGY. 2004; 1: 13-21

875

13535 Scarmeas N, Honig LS

Frontotemporal degenerative dementias

CLINICAL NEUROSCIENCE RESEARCH. 2004 MAR-APR; 3 (6): 449-460

201

876

14425 Forman MS, Trojanowski JQ, Lee VMY

Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs

NATURE MEDICINE. 2004 OCT; 10 (10): 1055-1063

206

104

877

14526 Healy DG, Abou-Sleiman PM, Wood NW

PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism

LANCET NEUROLOGY. 2004 NOV; 3 (11): 652-662

128

878

14576 Hodara R, Norris EH, Giasson BI, Mishizen-Eberz AJ, Lynch DR, et al.

Functional consequences of alpha-synuclein tyrosine nitration - Diminished binding to lipid vesicles and increased fibril formation

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 NOV 12; 279 (46): 47746-47753

879

14966 King ME

Can tau filaments be both physiologically beneficial and toxic?

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 260-267

880

16813 Uryu K, Richter-Landsberg C, Welch W, Sun E, Goldbaum O, et al.

Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies

AMERICAN JOURNAL OF PATHOLOGY. 2006 MAR; 168 (3): 947-961

Date / Author / Journal

LCS

GCS

LCR

881

17440 Schindowski K, Bretteville A, Leroy K, Begard S, Brion JP, et al.

Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits

AMERICAN JOURNAL OF PATHOLOGY. 2006 AUG; 169 (2): 599-616

882

17448 Surgucheva I, McMahon B, Surguchov A

gamma-Synuclein has a dynamic intracellular localization

CELL MOTILITY AND THE CYTOSKELETON. 2006 AUG; 63 (8): 447-458

883

18777 Terni B, Rey MJ, Boluda S, Torrejon-Escribano B, Sabate MP, et al.

Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer's disease

ACTA NEUROPATHOLOGICA. 2007 APR; 113 (4): 403-416

884

18817 Tsigelny IF, Bar-On P, Sharikov Y, Crews L, Hashimoto M, et al.

Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein

FEBS JOURNAL. 2007 APR; 274 (7): 1862-1877

885

19038 Emadi S, Barkhordarian H, Wang MS, Schulz P, Sierks MR

Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein- induced toxicity

JOURNAL OF MOLECULAR BIOLOGY. 2007 MAY 11; 368 (4): 1132-1144

886

19126 Mazanetz MP, Fischer PM

Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases

NATURE REVIEWS DRUG DISCOVERY. 2007 JUN; 6 (6): 464-479

164

887

19816 Jiang HB, Wu YC, Nakamura M, Liang YD, Tanaka YJ, et al.

Parkinson's disease genetic mutations increase cell susceptibility to stress: Mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death

NEUROBIOLOGY OF AGING. 2007 NOV; 28 (11): 1709-1717

888

20140 Gotz J, Ittner LM, Fandrich M, Schonrock N

Is tau aggregation toxic or protective: A sensible question in the absence of sensitive methods?

JOURNAL OF ALZHEIMERS DISEASE. 2008; 14 (4): 423-429

889

20344 Eriksen JL, Mackenzie IRA

Progranulin: normal function and role in neurodegeneration

JOURNAL OF NEUROCHEMISTRY. 2008 JAN; 104 (2): 287-297

890

20567 Mihajlovic M, Lazaridis T

Membrane-bound structure and energetics of alpha-synuclein

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS. 2008 FEB 15; 70 (3): 761-778

Date / Author / Journal

LCS

GCS

LCR

891

20975 Yu WH, Matsuoka Y, Sziraki I, Hashim A, LaFrancois J, et al.

Increased dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in transgenic mice expressing mutant A53T alpha-synuclein

NEUROCHEMICAL RESEARCH. 2008 MAY; 33 (5): 902-911

892

21223 Reynolds CH, Garwood CJ, Wray S, Price C, Kellie S, et al.

Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase C gamma 1, Grb2, and Src family kinases

JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 JUN 27; 283 (26): 18177-18186

893

21268 Deshpande A, Win KM, Busciglio J

Tau isoform expression and regulation in human cortical neurons

FASEB JOURNAL. 2008 JUL; 22 (7): 2357-2367

894

21727 Shadrina MI, Slominsky PA

Mitochondrial Dysfunction and Oxidative Damage in the Molecular Pathology of Parkinson's Disease

MOLECULAR BIOLOGY. 2008 OCT; 42 (5): 720-728

895

22111 Haydar SN, Yun HED, Staal RGW, Hirst WD

Small-Molecule Protein-Protein Interaction Inhibitors as Therapeutic Agents for Neurodegenerative Diseases: Recent Progress and Future Directions

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 44. 2009; 44: 51-69

896

22688 Marongiu R, Spencer B, Crews L, Adame A, Patrick C, et al.

Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux

JOURNAL OF NEUROCHEMISTRY. 2009 MAR; 108 (6): 1561-1574

897

23078 Han D, Qureshi HY, Lu YF, Paudel HK

Familial FTDP-17 Missense Mutations Inhibit Microtubule Assembly- promoting Activity of Tau by Increasing Phosphorylation at Ser(202) in Vitro

JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 MAY 15; 284 (20): 13422-13433

898

23279 Tsang AHK, Chung KKK

Oxidative and nitrosative stress in Parkinson's disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 643-650

121

899

23894 Morfini GA, Burns M, Binder LI, Kanaan NM, LaPointe N, et al.

Axonal Transport Defects in Neurodegenerative Diseases

JOURNAL OF NEUROSCIENCE. 2009 OCT 14; 29 (41): 12776-12786

125

900

23940 Gitcho MA, Bigio EH, Mishra M, Johnson N, Weintraub S, et al.

TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy

ACTA NEUROPATHOLOGICA. 2009 NOV; 118 (5): 633-645

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records